Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andreas Marti
Institutions:
University of Bern,
Swissmedic
Observed institutions:
University of Bern,
Swissmedic,
University Hospital of Bern
ORCID:
0009-0006-8847-3241
Observed ORCID:
0009-0006-8847-3241
OpenAlex ID:
A5080748959
The Regulation of Cell Therapy and Gene Therapy Products in Switzerland
2023
·
Petra Kempná Bukovac
, Michel Hauser
, et al.
·
Advances in experimental medicine and biology
·
8
Biodistribution studies: understanding international expectations
2016
·
Ying Huang
, Mike Havert
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
5
PDF
Requirements for Clinical Trials with Gene Therapy and Transplant Products in Switzerland
2015
·
Andreas Marti
·
Advances in experimental medicine and biology
·
5
Physician perspectives on statin continuation and discontinuation in older adults in primary cardiovascular prevention: a qualitative methods study
2024
·
Andreas Marti
, Samuel Zbinden
, et al.
·
BMJ Open
·
2
PDF
IPRF Reflection Paper on Biodistribution
2018
·
Mike Havert
, Ying Huang
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
1
PDF
Swissmedic Innovation Office: early regulatory engagement to accelerate ATMP clinical development—regulatory insights and recommendations
2026
·
Michel Hauser
, Alexander Reichenbach
, et al.
·
Cytotherapy
Show more works
View as search
Works count:
6
Citation count:
21
H-index:
3
I10-index:
Year
Topic
Type
